{"id":"W2162342078","doi":"10.1109/icmens.2004.1508923","title":"Preliminary Results of Nanopharmaceuticals Used in the Radioimmunotherapy of Ovarian Cancer","year":2006,"lang":"en","type":"article","venue":"","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Alberta","funders":"","keywords":"Radioimmunotherapy; Monoclonal antibody; Ovarian cancer; Cancer research; Biotinylation; In vivo; Epitope; Cytotoxic T cell; Pretargeting; Radionuclide therapy; Adjuvant; Medicine; Pharmacology; Chemistry; Cancer; Antibody; Biology; Immunology; Internal medicine; In vitro; Biochemistry","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004870488,0.000309822,0.0002205367,0.0002326052,0.0001585413,0.0002552185,0.0001748839,0.0004068003,0.001011635],"category_scores_gemma":[0.0004150437,0.00009399017,0.0002495495,0.0001491508,0.000240891,0.0001757605,0.000181366,0.0002704067,0.0002619669],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002329483,"about_ca_system_score_gemma":0.0001667159,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005572067,"about_ca_topic_score_gemma":0.0005816701,"domain_scores_codex":[0.9997618,0.00009438483,0.0000196233,0.00002559684,0.0000632458,0.00003529117],"domain_scores_gemma":[0.9997837,0.00009409372,0.00003481966,0.00002056624,0.00003752153,0.00002937237],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.001161238,0.0005346389,0.001118635,0.000263743,0.0000341851,0.00009434408,0.00006278219,0.0004958745,0.9794081,0.00008311088,0.0000933437,0.01664996],"study_design_scores_gemma":[0.0000700636,0.008061088,0.002985776,0.00001022379,0.00006648707,0.0002026604,0.00002084445,0.0004411254,0.985505,0.00002853319,0.002604102,0.000004188006],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9859539,0.00742579,0.003863732,0.0001102566,0.00002273998,0.0001979819,0.0001676035,0.00004560306,0.002212502],"genre_scores_gemma":[0.9897751,0.003433636,0.004039094,0.00008046981,0.00001885095,0.00009105468,0.000478515,0.00001440778,0.002068859],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001011635,"threshold_uncertainty_score":0.003384292,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0413809442045454,"score_gpt":0.3689286778625529,"score_spread":0.3275477336580075,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}